PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Pathology and Translational Medicine10.4132/jptm.2016.08.31201751140-48PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma PatientsJiheun Han, Yongkil Hong, Youn Soo Leehttp://www.jpatholtm.org/journal/view.php?doi=10.4132/jptm.2016.08.31, http://www.jpatholtm.org/upload/pdf/jptm-2016-08-31.pdf, http://www.jpatholtm.org/upload/pdf/jptm-2016-08-31.pdf
BMJ10.1136/bmj.k35292018k3529Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysisXian Shen, Bin Zhaohttp://data.bmj.org/tdm/10.1136/bmj.k3529, https://syndication.highwire.org/content/doi/10.1136/bmj.k3529
European Journal of Cancer10.1016/s0959-8049(16)31464-2201551S5292647 Prognostic significance of PD-L1 expression on tumor-infiltrating mononuclear cells in patients with urothelial carcinomaS. Lim, J.W. Seo, S.Y. Rhahttps://api.elsevier.com/content/article/PII:S0959804916314642?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0959804916314642?httpAccept=text/plain
10.21203/rs.3.rs-1248240/v12022Dynamic Changes of Peripheral Blood Markers Predict Prognosis of Patients with Advanced Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 TreatmentGaoyan Tang, Yan Liu, Qingyun Zhang, Baohong Yang, Yanhong Ding, Guohua Yuhttps://www.researchsquare.com/article/rs-1248240/v1, https://www.researchsquare.com/article/rs-1248240/v1.html
Cancers10.3390/cancers12113276202012113276iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung CancerAlexandra Giatromanolaki, Avgi Tsolou, Eleftheria Daridou, Maria Kouroupi, Katerina Chlichlia, Michael I. Koukourakishttps://www.mdpi.com/2072-6694/12/11/3276/pdf
Cancers10.3390/cancers1206138620201261386Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma SubtypesCatarina Nascimento, Ana Catarina Urbano, Andreia Gameiro, João Ferreira, Jorge Correia, Fernando Ferreirahttps://www.mdpi.com/2072-6694/12/6/1386/pdf
Journal of the Egyptian National Cancer Institute10.1016/j.jnci.2018.08.0032018304125-131Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patientsDina M. El-Guindy, Duaa S. Helal, Nesreen M. Sabry, Mohamed Abo El-Nasrhttps://api.elsevier.com/content/article/PII:S1110036218300578?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1110036218300578?httpAccept=text/plain
Oncologie10.32604/oncologie.2021.0172202021233439-452Clinical Significance of PD-L1 Expression and CD8-Positive Tumor-Infiltrating Lymphocytes in Patients with Cavitary Lung AdenocarcinomaJiangyong Liu, Mingming Gu, Yang Xue, Qiong Wang, Yong Ren, Wencai Huanghttps://www.techscience.com/oncologie/v23n3/44586/pdf
Head and Neck Pathology10.1007/s12105-017-0857-32017122221-229Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell CarcinomaTheresa Scognamiglio, Yao-Tseng Chenhttp://link.springer.com/article/10.1007/s12105-017-0857-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12105-017-0857-3.pdf, http://link.springer.com/content/pdf/10.1007/s12105-017-0857-3.pdf
Respirology10.1111/resp.13420_231201823172-172AN IMMUNE PROFILE OF TUMOR PD-L1 EXPRESSION PLUS CD4 OR CD8 T CELL INFILTRATIONS CORRELATED WITH TREATMENT EFFICACY OF PD-1 BLOCKADE ANTIBODIES IN NSCLC PATIENTShttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13420_231, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13420_231/fullpdf